At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.
about
At the crossroads from bench to bedside: luteolin is a promising pharmacological agent against myocardial ischemia reperfusion injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
At the crossroads from bench t ...... l ischemia reperfusion injury.
@en
At the crossroads from bench t ...... l ischemia reperfusion injury.
@nl
type
label
At the crossroads from bench t ...... l ischemia reperfusion injury.
@en
At the crossroads from bench t ...... l ischemia reperfusion injury.
@nl
prefLabel
At the crossroads from bench t ...... l ischemia reperfusion injury.
@en
At the crossroads from bench t ...... l ischemia reperfusion injury.
@nl
P2860
P921
P356
P1476
At the crossroads from bench t ...... l ischemia reperfusion injury.
@en
P2093
P2860
P356
10.21037/ATM.2016.11.56
P577
2016-12-01T00:00:00Z